THC medication eliminates PTSD nightmares in over one-third of patients

For those whose trauma does not end when they close their eyes, the night becomes an extension of the wound. Researchers at Charité—Universitätsmedizin Berlin have found that Dronabinol, a prescription form of THC, significantly reduced nightmare frequency and severity in PTSD patients over a ten-week clinical trial — with more than a third experiencing complete cessation. The finding points toward a gap long left open by conventional psychiatry: that the sleeping mind, replaying what the waking mind cannot resolve, may respond to a different kind of medicine altogether. Whether this becomes a